Background Anxiety and related disorders are among the most common mental disorders,
with lifetime prevalence reportedly as high as 31%. Unfortunately, anxiety disorders are …

Background Current clinical practice guidelines (CPGs) for posttraumatic stress disorder
(PTSD) offer contradictory recommendations regarding use of medications or psychotherapy …

BackgroundPharmacological treatment is widely used for post-traumatic stress disorder
(PTSD) despite questions over its efficacy. AimsTo determine the efficacy of all types of …

Posttraumatic stress disorder (PTSD) is a chronic psychological disorder that can develop
after exposure to a traumatic event. This review summarizes the literature on the …

We report follow-up data evaluating the long-term outcomes for the first completed trial of 3,
4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for chronic, treatment …

Anxiety disorders, as a group, are among the most common mental health conditions and
frequently cause significant functional impairment. Both psychotherapeutic and …

Post-traumatic stress disorder (PTSD) can become a chronic and severely disabling
condition resulting in a reduced quality of life and increased economic burden. The disorder …

Pharmacotherapy for post traumatic stress disorder (PTSD) - Stein, DJ - 2006 | Cochrane
Library Skip to Content Cookies Our site uses cookies to improve your experience. You can …

In this report, which is an update of a guideline published in 2002 (Bandelow et al. 2002,
World J Biol Psychiatry 3: 171), recommendations for the pharmacological treatment of …

These British Association for Psychopharmacology guidelines cover the range and aims of
treatment for anxiety disorders. They are based explicitly on the available evidence and are …